FFA
REGN icon

Farther Finance Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Farther Finance Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$671K Sell
1,075
-795
-43% -$541K 0.01% 1342
2026
Q1 		$1.45M Sell
1,870
-122
-6% -$93.4K 0.01% 789
2025
Q4 		$1.54M Buy
1,992
+513
+35% +$348K 0.02% 696
2025
Q3 		$832K Buy
1,479
+848
+134% +$479K 0.01% 824
2025
Q2 		$331K Buy
631
+3
+0.5% +$1.67K 0.01% 1126
2025
Q1 		$387K Buy
628
+55
+10% +$37.8K 0.01% 912
2024
Q4 		$409K Sell
573
-151
-21% -$127K 0.01% 670
2024
Q3 		$761K Buy
724
+53
+8% +$59K 0.03% 439
2024
Q2 		$710K Buy
671
+31
+5% +$30.1K 0.03% 375
2024
Q1 		$621K Buy
640
+4
+0.6% +$3.8K 0.04% 345
2023
Q4 		$558K Buy
636
+149
+31% +$123K 0.04% 327
2023
Q3 		$401K Buy
487
+190
+64% +$149K 0.06% 237
2023
Q2 		$213K Buy
297
+189
+175% +$146K 0.05% 302
2023
Q1 		$88.7K Buy
108
+2
+2% +$1.51K 0.03% 433
2022
Q4 		$76.5K Buy
+106
New +$78.2K 0.03% 387

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Farther Finance Advisors's REGN Position: Q2 2026 in Review

Farther Finance Advisors reduced its Regeneron Pharmaceuticals (REGN) stake by 43% in Q2 2026, selling an estimated $541K and leaving 1,075 shares worth $671K. The position accounts for 0.01% of the portfolio, ranked #1342.

Farther Finance Advisors first reported a position in REGN in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.54M in Q4 2025. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Farther Finance Advisors held 1,075 shares of Regeneron Pharmaceuticals worth $671K as of Q2 2026.
  • Farther Finance Advisors sold 795 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $541K.
  • Regeneron Pharmaceuticals made up 0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #1342 holding.
  • Farther Finance Advisors first reported a position in Regeneron Pharmaceuticals in Q4 2022 and has held it in 15 quarters since.
  • Farther Finance Advisors's Regeneron Pharmaceuticals position peaked at $1.54M in Q4 2025.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.